Navigation Links
Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
Date:8/20/2008

Collaboration Will Seek to Identify microRNAs Implicated in HIV Viral

Replication and Their Function Samples Will be Screened and Analyzed Using Rosetta Genomics' Proprietary

microRNA Technologies

REHOVOT, Israel and JERSEY CITY, New Jersey, August 20 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify microRNAs involved in the progression of the Human Immunodeficiency Virus (HIV), that may be used as potential drug targets.

Rosetta Genomics has access to the majority of known human and viral microRNAs. From this strong intellectual property position, the company has developed highly sensitive, proprietary technologies to detect and quantify microRNAs. These technologies are based on publicly known human and viral microRNAs in addition to Rosetta Genomics proprietary microRNAs, which are yet to be published. Leveraging Rosetta Genomics' extensive know-how in microRNAs and proprietary technologies, this collaboration will seek to determine the role of microRNAs in HIV viral replication, and their potential to act as novel drug targets for future therapy.

"We are very excited to be collaborating with the NIH in seeking to better understand the link between the aberrant expression of microRNAs and the viral replication of HIV, and to identify potential microRNA drug targets", said Dr. Zvi Bentwich, Chief Scientist of Rosetta Genomics and a world renowned HIV researcher. "Having the opportunity to work with the NIH on this important collaboration is a reflection on our leading capabilities and know how in this field."

In a study published last year (Zhang et al. Nature Medicine, 2007), researchers showed that microRNAs are involved in suppressing HIV replication' and keeping it latent. Through this collaboration, Rosetta Genomics and the NIH aim to deepen the understanding of the role microR
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Rosetta Genomics Reports Second Quarter 2008 Financial Results
2. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
3. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
4. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
5. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
6. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
7. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
8. /C O R R E C T I O N -- Rosetta Genomics Ltd/
9. Rosetta Genomics Reports First Quarter 2008 Financial Results
10. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
11. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosystem... re-filed the Form 52-109F1 Certification of Annua...fficer and James Long, the Chief Financial Officer...2009 in connection with the annual audited financi...8. ,, The Company initially filed the annual fi...
(Date:11/6/2009)..., Calif., Nov. 6 ,, ...ansfer of Qutenza(TM) E.U. Marketing Authorization... progress in commercial readiness activities Expa...irector, Marketing; and Director, Commercial Opera...irector and Audit Committee chairman , Upco...
(Date:11/5/2009)...TION -- Gone hybrid . . . , Fuel economy ratin... posted at the www.fueleconomy.gov web site, whi...ntains for the U.S. Department of Energy and the U...op 10 vehicles on the best fuel economy list are h...ity; 48 highway). "This list proves that hybrids h...
(Date:11/5/2009)...RDOVA, Calif., Nov. 5 Th...lier of innovative products for processing and sto...the first quarter of fiscal 2010. ,, For the qu...ed revenues of $5.2 million, a 15 percent increase...r a year ago. The Company said the key contributor...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...vestor Syndicate, VIENNA, Austria, March 28 f-st...el antibodies and antibody fragments,based on its ...y that it,has acquired future royalty obligations ... payment., Modular Antibody Technology was origin...tar,s founders, in collaboration with NCP, a U.S.,...
...March 28 Mentice AB, a leading,supplier of virtua...ield of,medicine has recently appointed Lars Lonn ..., an Interventional Radiologist, is also a leading...ar Surgery and a faculty,member of Rigshospital He...Lonn recently completed a study with Max Berry, MD...
...Scientists have developed a new form of stretchabl...complex shapes such as spheres, body parts and air...mpressing, folding and other types of extreme mech...ical performance. , The notion that silicon cannot...sically brittle and rigid has been tossed out the ...
Other Biology Technology:Antibody Engineering Company F-Star Buys Back Royalty Obligations 2Foldable and stretchable, silicon circuits conform to many shapes 2Foldable and stretchable, silicon circuits conform to many shapes 3
(Date:11/8/2009)...LTH EDUCATION DESIGNED FOR ADULTS WITH INTELLECTUA... , An Indiana University study involving adults...lts increased their personal health knowledge afte...Adults with ID, an internationally accepted term f...of obesity, physical inactivity and preventable ch...
(Date:11/6/2009)...LPHIA (November 06, 2009) The Monell Center and t...of the Beijing International Meeting on Taste and ...on with the CAS, the meeting will be the first int...n China. , Alan Leshner, Chief Executive Officer...nce and Executive Publisher of Science magazine, w...
(Date:11/4/2009)...S: (top news in natural science) , United Stat...ses less water today than it did 35 years ago, des... water use are partly attributable to alternative ... irrigation systems. According to the latest USGS ... the United States goes to cooling thermoelectric ...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Running a Marathon The realbuzz com Beginners Guide 58910 1Running a Marathon The realbuzz com Beginners Guide 58910 2Running a Marathon The realbuzz com Beginners Guide 58910 3News briefs from the October issue of Chest 58908 1News briefs from the October issue of Chest 58908 2Cytopia Merger with Toronto based YM BioSciences Inc 14360 1Cytopia Merger with Toronto based YM BioSciences Inc 14360 2Cytopia Merger with Toronto based YM BioSciences Inc 14360 3Cytopia Merger with Toronto based YM BioSciences Inc 14360 4Cytopia Merger with Toronto based YM BioSciences Inc 14360 5Cytopia Merger with Toronto based YM BioSciences Inc 14360 6Cytopia Merger with Toronto based YM BioSciences Inc 14360 7
...ngoing quest, a group of Scripps Research Institut...rsity of California, San Diego, (UCSD) have borrow...aritiesan unmitigated success. The group has devis...curacy, predicts how bacterial proteins fold and i..., described in this week,s Early Edition of the P...
...ncer is typically without symptoms until it has sp...ficult to treat. Newer chemotherapies show great p... stages, but they can also be highly toxic. , In...s Cancer Center researchers have identified ways t...in so doing, help make chemotherapy for kidney can...
... acts as a computer to both store information and ...devices perform these roles; while a hard disk sto... does the processing. But the brain is thought to ...urons leading researchers to ask if distinct mole... functions. , In a discovery that may one day le...
Other Biology News:New technique is quantum leap forward in understanding proteins 2New technique is quantum leap forward in understanding proteins 3New technique is quantum leap forward in understanding proteins 4UC Davis discovery offers hope for treating kidney cancer 2SUNY Downstate researchers find that memory storage molecule preserves complex memories 2
BMP-2 ELISA Kit from R&D Systems
5x MONO-RABBIT POLY C'GATE DILUENT from AbD Serotec
Argarase from BioVision
SAMPLE DILUENTS BUFFER TRIAL PACK from AbD Serotec
Biology Products: